Quick Answer
Strata Critical Medical, Inc. reported Cash and Equivalents of $30.97 million for fiscal year 2025.
Strata Critical Medical, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $30.97M | +68.5% |
| 2024 | $18.38M | -34.1% |
| 2023 | $27.87M | -32.6% |
| 2022 | $41.34M | +1493.0% |
| 2021 | $2.60M | -62.7% |
| 2021 | $6.95M | +721.7% |
| 2020 | $846.1K | -93.0% |
| 2020 | $12.16M | +831.5% |
| 2019 | $1.31M | -94.1% |
| 2019 | $22.18M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $22.75M | +13.6% | -61.3% |
| June 30, 2025 | $58.75M | +123.3% | +68.7% |
| March 31, 2025 | $34.83M | -5.2% | +116.7% |
| December 31, 2024 | $16.07M | -42.3% | -19.8% |
| September 30, 2024 | $20.03M | -45.6% | -23.9% |
| June 30, 2024 | $26.31M | -29.6% | -28.4% |
| March 31, 2024 | $36.76M | -11.9% | +31.9% |
| December 31, 2023 | $27.87M | -35.6% | -24.3% |
- Strata Critical Medical, Inc. showed an increase of +68.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2019–2025 period, Strata Critical Medical, Inc.’s cash and equivalents has grown by 39.6% (from $22.18 million to $30.97 million).
- The most recent figure is from Strata Critical Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: